US Patent Issued to Adaptate Biotherapeutics on Aug. 11 for "Anti-TCR delta variable 1 antibodies" (British Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,703,746, issued on Aug. 11, was assigned to Adaptate Biotherapeutics Ltd. (London).

"Anti-TCR delta variable 1 antibodies" was invented by Mihriban Tuna (London), Oxana Polyakova (London), Mark Uden (London), Robert Good (London), Joshua Freedman (London), Shefali Bhumbra (London), Natalie Mount (London), Aoife McGinley (London) and Dan Foxler (London).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides high-affinity anti-TCR delta variable 1 (anti-VDelta1) antibodies and antibody fragments thereof. The present invention also provides compositions and pharmaceutical compositions comprising such antibodies, and method of making s...